Insider Transactions in Q4 2022 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2022
|
Niall O'Donnell Director |
SELL
Open market or private sale
|
Indirect |
93,770
-5.47%
|
$1,781,630
$19.69 P/Share
|
|
Nov 14
2022
|
Niall O'Donnell Director |
SELL
Open market or private sale
|
Indirect |
32,109
-1.84%
|
$610,071
$19.6 P/Share
|
|
Nov 11
2022
|
Niall O'Donnell Director |
SELL
Open market or private sale
|
Indirect |
174,121
-9.06%
|
$3,308,299
$19.99 P/Share
|
|
Nov 10
2022
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
82
+0.08%
|
$1,394
$17.05 P/Share
|
|
Nov 10
2022
|
Peter Radovich PRESIDENT AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
292
+1.22%
|
$4,964
$17.05 P/Share
|
|
Nov 10
2022
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
660
+2.93%
|
$11,220
$17.05 P/Share
|
|
Nov 10
2022
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
49
+0.07%
|
$833
$17.05 P/Share
|
|
Nov 10
2022
|
Ian Clements Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
325
+1.07%
|
$5,525
$17.05 P/Share
|